CNK, FANG and OMCL gain momentum from upward broker rating revisions, backed by strong projected 2026 earnings growth.
AVT, OMCL, HPE and LCUT stand out as undervalued stocks, backed by strong earnings surprises, attractive valuations and robust projected growth.
Detailed price information for Fractyl Health Inc (GUTS-Q) from The Globe and Mail including charting and trades.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at healthcare technology for providers stocks, starting with Omnicell (NASDAQ:OMCL).
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
Omnicell trades around US$33.17 after a mixed share price record, and the key issue now is whether that level lines up with the cash the business can generate over time. With the stock showing both long slumps and shorter rebounds, investors are left asking how closely the current market value tracks the company’s underlying cash flows. Over the past 5 years the share price has fallen 77.7%, which puts the spotlight firmly on whether the long term cash flow potential still supports today’s...
TraceLink, the world's largest Agentic Business Network for the life sciences and healthcare supply chain, today announced an integration between its Drug Supply Chain Security Act (DSCSA) compliance solution and the pharmacy inventory management systems of Omnicell, Inc. (Nasdaq: OMCL), a leading healthcare technology provider focused on empowering autonomous medication management. This integration is expected to enable hospitals and health systems to manage product verification, traceability,
FORT WORTH, Texas, August 31, 2026--Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
This is the newest page. Registered accounts read further back.